10-Q

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: March 31, 2014

or

[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

For the transition period from ________________ to __________________

Commission File Number 333-184459

800 COMMERCE, INC.

(Exact name of registrant as specified in its charter)

Florida 27-2019626

(State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.)

319 Clematis Street, Suite 1008, West Palm Beach, FL 33401

(Address of principal executive offices)

(561) 249-6511

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes☒ No ☐

Indicate by check mark whether the registrant is a larger accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of "accelerated filer and large accelerated filer" in Rule 12b-2 of the Exchange Act. (Check one)

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☐  (Do not check if a smaller reporting company)	Smaller reporting company ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The number of shares outstanding of the Registrant's $0.01 par value Common Stock as of May 15, 2014, was 19,950,000 shares.

(1)

Index to Condensed Financial Statements

		Page No.
Part I Financial Information
Item 1.	Financial Statements
	Condensed Balance Sheets as of March 31, 2014 (Unaudited) and December 31, 2013	F-1
	Condensed Statements of Operations and Comprehensive Income for the three months ended March 31, 2014 and 2013 (Unaudited)	F-2
	Condensed Statements of Cash Flows for the three months ended March 31, 2014 and 2013	F-3
	Notes to Condensed Financial Statements	F-4-F13
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	16
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	19
Item 4.	Controls and Procedures	19
Part II Other Information
Item 1.	Legal Proceedings	19
Item 1A.	Risk Factors	19
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	19
Item 3.	Defaults Upon Senior Securities	19
Item 4.	Mine Safety Disclosure	19
Item 5.	Other Information	19
Item 6.	Exhibits	20
	Signatures	21

(2)

800 COMMERCE, INC.
CONDENSED BALANCE SHEETS
	March 31,			December 31,
	2014			2013
	(unaudited)
ASSETS
Current Assets:
Cash and cash equivalents	$	9,395		$	3,912
Accounts receivable		30,606			29,159
Prepaid expenses		1,500			—
Marketable securities		263,400			72,150
Security deposit		700			—
Total current assets		305,601			105,221
Patents Pending		33,950			33,950
Property and equipment, net		2,413			2,512
Total assets	$	341,964		$	141,683
LIABILITIES AND STOCKHOLDERS' EQUITY  (DEFICIT)
Current Liabilities:
Accounts payable and accrued expenses	$	84,523		$	76,697
Due to related parties		195,558			174,408
Convertible promssory note		—			7,000
Derivative liability		—			6,373
Total current liabilities		280,081			264,478
Stockholders' Equity (Deficit):
Preferred stock, $0.001 par value; 10,000,000 shares authorized, none issued		—			—
Common stock, $0.001 par value; 90,000,000 shares authorized; 19,950,000
shares issued and outstanding		19,950			19,950
Additional paid-in capital		1,425,252			1,418,879
Accumulated comprehensive gain (loss)		149,400			(51,350	)
Accumulated deficit		(1,532,719	)		(1,510,274	)
Total stockholders' equity (deficit)		61,883			(122,795	)
Total liabilities and stockholders' equity (deficit)	$	341,964		$	141,683
See notes to condensed financial statements.

(3)

800 COMMERCE, INC.
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(Unaudited)
	Three months ended March 31,
	2014			2013
				(Restated)
Free revenue, net	$	90,448		$	93,812
Costs of revenue		89,607			113,253
Gross profit		841			(19,441	)
Operating expenses:
Salaries and management fees (includes $75,500 (2013)
of stock based compensation)		22,500			90,303
Rent		—			5,437
Travel and entertainment		—			2,406
Transfer agent and filing fees		2,970			1,832
Professional and consulting fees		3,150			5,962
Software development and internet expenses		873			1,711
Other general and administrative		847			12,660
Total operating expenses		30,340			120,311
Operating loss		(29,499	)		(139,752	)
Other income (expense):
Interest expense		—			(13,329	)
Change in fair market value of derivative liabilities		—			11,180
Gain on sale of marketable securities		7,054			3,174
Total other income, net		7,054			1,025
Net loss	$	(22,445	)	$	(138,727	)
Other Comprehensive gain, net of tax:
Unrealized gain on marketable securities	$	207,804		$	348,074
Less reclassiifcation adjustment for gains
included in net loss		(7,054	)		(3,174	)
Other comprehensive income		200,750			344,900
Comprehensive income	$	178,305		$	206,173
Net loss per share	$	(0.00	)	$	(0.01	)
Weighted average number of common shares outstanding
Basic and diluted		19,950,000			19,050,000
See notes to condensed financial statements.

(4)

800 COMMERCE, INC.
CONDENSED STATEMENTS OF CASH FLOWS
(Unaudited)
	Three months ended March 31,
	2014			2013 (Restated)
Cash flows from operating activities:
Net loss	$	(22,445	)	$	(138,727	)
Adjustments to reconcile net loss
to net cash used in operating activities:
Depreciation		99			99
Amortization of discount on convertible note		—			12,329
Change in fair value of derivative liabilities		—			(11,180	)
Stock based compensation		—			106,750
Gain on sale of marketable securities		(7,054	)		1,900
Change in operating assets and liabilities:
Increase in accounts receivable		(1,447	)		(3,126	)
Increase in prepaid assets		(1,500	)		—
Increase in security deposit		(700	)		—
Increase in accounts payable and accrued expenses		7,826			4,558
Net cash used in operating activities		(25,221	)		(27,397	)
Cash flows from investing activities:
Proceeds from sale of marketable securities		16,554			—
Purchase of computer equipment		—			(1,929	)
Net cash provided by (used in) investing activities		16,554			(1,929	)
Cash flows from financing activities:
Increase in amount due shareholders		21,150			1,701
Repayments of convertible note		(7,000	)		—
Net cash provided by financing activities:		14,150			1,701
Net increase (decrease) in cash and cash equivalents		5,483			(27,625	)
Cash and cash equivalents, beginning		3,912			40,618
Cash and cash equivalents, ending	$	9,395		$	12,993
Supplemental disclosure of cash flow information:
Cash paid for interest	$	—		$	—
Cash paid for income taxes	$	—		$	—
Schedule of Non-Cash Investing and Financing Activities
Reclassification of derivative liability upon repayment of convertible debt	$	6,373		$	—
See notes to condensed financial statements.

(5)

800 COMMERCE, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

Note 1 - Organization

Business

800 Commerce, Inc. (the “Company” or “800 Commerce”) was formed in the State of Florida on February 10, 2010. The Company was founded for the purpose of marketing credit card processing services on behalf of merchant payment processing service providers. The Company commenced revenue producing activities based on the marketing of credit processing services in March 2010. The Company generates revenue from the marketing of credit processing services by way of fees received from merchant payment processing service providers on whose behalf the Company brokers their processing services. On August 1, 2012, the Company began to receive additional revenue pursuant to a processing service provider’s assignment to the Company of a portion of its fee income under one of its service contracts in exchange for the issuance of 500,000 shares of our common stock.

In addition to marketing credit card processing services, the Company also has developed on-line portals and mobile applications offering directories of professional service providers. The Company has completed its’ initial on-line portal and mobile application dedicated to a directory of medical doctors, however the Company has not commenced revenue producing operations by way of the medical directory. The Company expects to re-launch the marketing of the medical directory in the second quarter of 2014, and hopes to commence receipt of revenue from the marketing of the medical directory in the third quarter of 2014.

On August 9, 2013, the Securities and Exchange Commission (the “SEC”) declared effective the Company’s Registration Statement on Form S-1/A, whereby the Company has registered the 6,000,000 shares of common stock owned by Mediswipe. Mediswipe distributed the 6,000,000 shares of common stock to their shareholders of record as of September 3, 2013. The shares were distributed on September 4, 2013.

In September 2013, the Company engaged a broker dealer, who has filed a Form 211 Application with the Financial Industry Regulatory Authority (“FINRA”) in order to obtain a symbol for quotation. The broker dealer is working with FINRA’s staff’s requests of the broker dealer in order to continue the review process. The Company and its counsel are closely monitoring the broker dealer’s response to FINRA. Pursuant to the SEC Rule 15C2-11, only the broker dealer can communicate with FINRA regarding this process.

(6)

Note 2 - Summary of Significant Accounting Policies

Basis of Presentation

The accompanying condensed financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments necessary to present the financial position, results of operations and cash flows for the stated periods have been made. Except as described below, these adjustments consist only of normal and recurring adjustments. Certain information and note disclosures normally included in the Company’s annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. These condensed financial statements should be read in conjunction with a reading of the Company’s consolidated financial statements and notes thereto included in the Company’s Form 10-K annual report filed with the Securities and Exchange Commission (SEC) on April 11, 2014. Interim results of operations for the three months ended March 31, 2014 are not necessarily indicative of future results for the full year. Certain amounts from the 2013 period have been reclassified to conform to the presentation used in the current period.

Restatement

The financial statements for the three months ended March 31, 2013 have been restated to amortize a portion of the fair value of common stock issued pursuant to the Assignment Agreement, which was previously expensed during 2012.

The following tables present the effects of the restatement adjustments on the affected line items in the previously reported statement of operations for the three months ended March 31, 2013. The restatement adjustments did not affect the statements of cash flows for the three months ended March 31, 2013 balance sheet with the exception of the decrease in retained deficit of $41,667, an increase in the amortization of $31,250 and a decrease of deferred equity consideration of $41,667. All related amounts have been restated as appropriate within these financial statements.

Three months ended March 31, 2013	As reported		Adjustments		Restated
Costs of revenues	$	82,003	$	31,250	$	113,253
Gross profit (loss)		11,809		(31,250)		(19,441)
Operating loss		(108,502)		(31,250)		(139,752)
Net loss		(107,477)		(31,250)		(138,727)
Comprehensive income		235,523		(31,250)		206,173
Net loss per share	$	(0.00)	$	(0.01)	$	(0.01)

Emerging Growth Company

We qualify as an “emerging growth company” under the 2012 JOBS Act. Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. As an emerging growth company, we can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of the benefits of this extended transition period.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents.

Accounts Receivable

The Company records accounts receivable from amounts due from its processors. The Company charges certain merchants for processing services at a bundled rate based on a percentage of the dollar amount of each transaction and, in some instances, additional fees are charged for each transaction. The Company charges other merchant customers a flat fee per transaction, and may also charge miscellaneous fees to customers, including fees for returns, monthly minimums, and other miscellaneous services. All the charges and collections thereon flow through processors who then remit the fee due the Company within the month following the actual charges.

(7)

Marketable Securities

The Company classifies its marketable securities as available-for-sale securities, which are carried at their fair value based on the quoted market prices of the securities with unrealized gains and losses, net of deferred income taxes, reported as accumulated other comprehensive income (loss), a separate component of stockholders’ equity. Realized gains and losses on available-for-sale securities are included in net earnings in the period earned or incurred.

Patents

The Company capitalizes patent pending acquisition costs, legal fees and filing costs associated with the development and filing of its patents.  Patents are generally amortized over an estimated useful life of 15 years using the straight-line method beginning on the issue date.  No amortization expense was recorded during the three months ended March 31, 2014 and 2013, as the Company’s patents are still pending as of March 31, 2014.

Revenue Recognition

The Company recognizes revenue in accordance with FASB ASC 605, Revenue Recognition. ASC 605 requires that four basic criteria are met (1) persuasive evidence of an arrangement exists, (2) delivery of products and services has occurred, (3) the fee is fixed or determinable and (4) collectability is reasonably assured. The Company recognizes revenue during the month in which commissions are earned.

Fair Value of Financial Instruments

Fair value measurements are determined under a three-level hierarchy for fair value measurements that prioritizes the inputs to valuation techniques used to measure fair value, distinguishing between market participant assumptions developed based on market data obtained from sources independent of the reporting entity (“observable inputs”) and the reporting entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (“unobservable inputs”). Fair value is the price that would be received to sell an asset or would be paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date. In determining fair value, the Company primarily uses prices and other relevant information generated by market transactions involving identical or comparable assets (“market approach”). The Company also considers the impact of a significant decrease in volume and level of activity for an asset or liability when compared with normal activity to identify transactions that are not orderly.

The highest priority is given to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Securities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

The three hierarchy levels are defined as follows:

Level 1 – Quoted prices in active markets that is unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2 – Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly;

Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

(8)

Credit risk adjustments are applied to reflect the Company’s own credit risk when valuing all liabilities measured at fair value. The methodology is consistent with that applied in developing counterparty credit risk adjustments, but incorporates the Company’s own credit risk as observed in the credit default swap market.

The Company's financial instruments consist primarily of marketable securities. Marketable securities are adjusted to fair value each balance sheet date, based on quoted prices; which are considered level 1 inputs (see Note 5). The estimated fair value is not necessarily indicative of the amounts the Company would realize in a current market exchange or from future earnings or cash flows.

The Company’s derivative liability resulting from the issuance of convertible debt is adjusted to fair value based on recent sales of the underlying common stock and the use of an option pricing model, which are consistent with level 3 inputs. See Note 6.

The following table represents the Company’s financial instruments that are measured at fair value on a recurring basis as of March 31, 2014 and December 31, 2013 for each fair value hierarchy level:

March 31, 2014	Derivative Liability		Marketable Securities		Total
Level I	$	—	$	263,400	$	263,400
Level II	$	—	$	—	$	—
Level III	$	—	$	—	$	—
December 31, 2013
Level I	$	—	$	72,150	$	72,150
Level II	$	—	$	—	$	—
Level III	$	6,373	$	—	$	6,373

The carrying amount of the Company’s accounts payable and accrued expenses, due to related parties and convertible debt approximate fair value to their short term.

Income Taxes

The Company accounts for income taxes in accordance with ASC 740-10, Income Taxes. The Company recognizes deferred tax assets and liabilities to reflect the estimated future tax effects, calculated at the tax rate expected to be in effect at the time of realization. The Company records a valuation allowance related to a deferred tax asset when it is more likely than not that some portion of the deferred tax asset will not be realized. Deferred tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates of the date of enactment.

ASC 740-10 prescribes a recognition threshold that a tax position is required to meet before being recognized in the financial statements and provides guidance on recognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition issues. The Company classifies interest and penalties as a component of interest and other expenses. To date, the Company has not been assessed, nor has the Company paid, any interest or penalties.

The Company measures and records uncertain tax positions by establishing a threshold for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Only tax positions meeting the more-likely-than-not recognition threshold at the effective date may be recognized or continue to be recognized. The Company’s tax years subsequent to 2010 remain subject to examination by federal and state tax jurisdictions.

Earnings (Loss) Per Share

The Company reports earnings (loss) per share in accordance with ASC 260, "Earnings per Share." Basic earnings (loss) per share is computed by dividing net income (loss), after deducting preferred stock dividends accumulated during the period, by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net income by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Potentially dilutive securities for the three months ended March 31, 2014 included options to purchase 1,600,000 shares of common stock, which were not included in the calculation of diluted loss per share because their impact was anti-dilutive.

Accounting for Stock-based Compensation 

The Company accounts for stock awards issued to non-employees in accordance with ASC 505-50, Equity-Based Payments to Non-Employees. The measurement date is the earlier of (1) the date at which a commitment for performance by the counterparty to earn the equity instruments is reached, or (2) the date at which the counterparty's performance is complete. Stock awards granted to non-employees are valued at their respective measurement dates based on the trading price of the Company’s common stock and recognized as expense during the period in which services are provided.

Comprehensive Income

The Company has adopted ASC Topic 220, "Comprehensive Income." This statement establishes standards for reporting comprehensive income and its components in a financial statement. Comprehensive income as defined includes all changes in equity (net assets) during a period from non-owner sources. Items included in the Company’s comprehensive loss consist of unrealized losses on available-for-sale securities.

(9)

Note 3 – Recent Accounting Pronouncements

Accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption.

Note 4 – Sales Concentration and Concentration of Credit Risk

Cash

Financial   instruments   that   potentially   subject   the   Company to concentrations of credit risk consist principally of cash. The Company maintains cash balances at one financial institution, which is insured by the Federal Deposit Insurance Corporation (“FDIC”). The FDIC insured institution insures up to $250,000 on account balances. The amounts that are not insured by FDIC limitations are held in short-term securities. The Company has not experienced any losses in such accounts.

Sales

For the three months ended March 31, 2014 and 2013, approximately 99% and 96%, respectively, of the Company’s revenues for each period, were received from one merchant service provider, pursuant to an Assignment Agreement (see Note 9). As of March 31, 2014, the Company had $29,723 (97% of accounts receivable) in accounts receivable from the same merchant service provider. The Company relies on a few processors to provide, on a non-exclusive basis, transaction processing and transmittal, transaction authorization and data capture, and access to various reporting tools.

Note 5 – Marketable Securities

The Company’s marketable securities consist solely of 600,000 and 1,000,000, as of March 31, 2014, and December 31, 2013, respectively, of shares of Mediswipe, Inc.’s (“Mediswipe”) common stock, issued to the Company in connection with the Company’s formation in 2010. The Company classifies its marketable securities as available-for-sale securities, which are carried at their fair value based on the quoted market prices of the securities with unrealized gains and losses, net of deferred income taxes, reported as accumulated other comprehensive income (loss), a separate component of stockholders’ equity. Realized gains and losses on available-for-sale securities are included in net earnings in the period earned or incurred. During the three months ended March 31, 2014, the Company sold 50,000 shares of stock and recognized a gain of $7,054. The fair value of the Company’s holdings in Mediswipe’s common stock totaled $263,400 and $72,150 as of March 31, 2014, and December 31, 2013, respectively.

The following summarizes the carrying value of marketable securities as of March 31, 2014 and December 31, 2013:

	2014		2013
Historical cost	$114,000		$123,500
Unrealized gain (loss) included in accumulated  other comprehensive gain (loss)		149,400		(51,350	)
Net carrying value	$	263,400	$	72,150

(10)

Note 6 – Related Party Transactions

Management Fees

During the three months ended March 31, 2014 and 2013 the Company expensed management fees of $13,500 and $3,003, respectively to or on behalf of the Company’s President, B. Michael Friedman, and $9,000 and $9,000, respectively, to the Company’s Chief Financial Officer, Barry Hollander. Effective August 1, 2012, the Company entered into two Advisory Board Agreements (“ABA”) pursuant to which, the Company granted to each of Dr. James Canton and Mr. Scott Climes a non-qualified stock option to purchase 800,000 shares of common stock of the Company at an exercise price of $0.30 per share. The options were granted under the 2012 Plan and have a three year term. Accordingly, for the three months ended March 31, 2013, the Company expensed $63,000 in stock compensation expense for options that vested during the period. Amounts due stockholders on the balance sheet as of March 31, 2014, and December 31, 2013 include Mr. Friedman $44,997(2014) and $32,847 (2013) and Mr. Canton $66,667 (2014 and 2013).

Amounts due Mediswipe, Inc.

As of December 31, 2012, Mediswipe, Inc, (“Mediswipe”) owned 6,000,000 shares of the Company’s common stock, representing approximately 32% of the Company’s outstanding common stock. Effective September 4, 2013, Mediswipe distributed the 6,000,000 shares of the Company’s common stock to their shareholders of record as of September 3, 2013 (see note 11). The Company and Mediswipe are commonly controlled due to common management and board members. The Company owes Mediswipe $83,895 and $74,895 as of March 31, 2014 and December 31, 2013, respectively, as a result of advances received from Mediswipe. These advances are non-interest bearing and are due on demand and are included in amounts due shareholders on the March 31, 2014, balance sheet herein.

Convertible Promissory Note

In May 2012, the Company entered into a note agreement with Mr. Climes, our Chief Executive Officer and a member of our board of directors, for the issuance of a convertible promissory note in the amount of $50,000 (the “Note”). Among other terms the Note was due one year from its issuance date, bears interest at 8% per annum, payable in cash or shares at the Conversion Price as defined herewith, and was convertible at a conversion price (the “Conversion Price”) for each share of common stock equal to 65% of the lowest closing bid price within five days of any conversion. Additionally, there are limitations on the holder’s right to convert whereby there cannot be any conversion that would cause the holders beneficial ownership to exceed 4.9% of the total issued and outstanding common stock of the Company. Upon the occurrence of an event of default, as defined in the Note, the Company was required to pay interest at 12% per annum and the holders may at their option declare the Note, together with accrued and unpaid interest, to be immediately due and payable. In addition, the Note provided for adjustments for dividends payable other than in shares of common stock, for reclassification, exchange or substitution of the common stock for another security or securities of the Company or pursuant to a reorganization, merger, consolidation, or sale of assets, where there is a change in control of the Company. During the year ended December 31, 2013, the Company repaid $43,000 of the Note. During the quarter ended March 31, 2014, the Company repaid the remainder of the Note due.

The Company determined that the conversion feature of the Note represented an embedded derivative since the Note was convertible into a variable number of shares upon conversion. Accordingly, the Note was not considered to be conventional debt under EITF 00-19 and the embedded conversion feature was required to be bifurcated from the debt host and accounted for as a derivative liability. Accordingly, the fair value of this derivative instrument was recorded as a liability on the balance sheet with the corresponding amount recorded as a discount to the Note. Such discount was accreted from the date of issuance to the maturity date of the Note. The change in the fair value of the derivative liability will be recorded in other income or expenses in the statement of operations at the end of each quarter, with the offset to the derivative liability on the balance sheet. The beneficial conversion feature included in the Note resulted in an initial debt discount of $50,000 and an initial loss on the valuation of derivative liabilities of $1,282 based on the initial fair value of the derivative liability of $51,282.

At December 31, 2012, the Company revalued the embedded derivative liability. For the period from issuance to December 31, 2012, the Company decreased the derivative liability of $51,282 by $11,282 resulting in a derivative liability of $40,000 at December 31, 2012. On the dates of repayment of $43,000 in 2013 of principal, the Company reclassed the fair value of related conversion feature, $25,329, to additional paid in capital. On the dates of repayment of $7,000 of principal, the Company reclosed the fair value of related conversion feature, $6,373, to additional paid in capital. 

(11)

Note 7 – Stockholders’ Equity

Stock Options

Effective August 1, 2012 the Company adopted the 2012 Equity Incentive Plan (the “2012 Plan”) whereby the Company has reserved five million shares of common stock to be available for grants pursuant to the 2012 Plan.

Effective August 1, 2012, the Company entered into two Advisory Board Agreements (“ABA”) pursuant to which, the Company granted to each of Dr. James Canton and Mr. Scott Climes a non-qualified stock option to purchase 800,000 shares of common stock of the Company at an exercise price of $0.30 per share. The options were granted under the 2012 Plan and have a three year term. Mr. Climes is now a member of the board of directors of the Company and Dr. Canton the Chairman of the Board of Directors of the Company at the time (resigned January 15, 2014). Pursuant to each ABA, 200,000 options immediately vested and an additional 50,000 vest under each ABA at the end August 2012 and for the following eleven months, as long as Messrs. Climes and Canton remain as a director.

A summary of the activity of options for the three months ended March 31, 2014 is as follows:

	Options		Weighted-Average exercise price		Weighted- Average grant date fair value
Balance January 1, 2014		1,600,000	$	0.30	$	0.21
Options granted		—		—		—
Outstanding as of March 31, 2014		1,600,000		0.30		0.21
Exercisable as of March 31, 2014		1,600,000		0.30		0.21

As of March 31, 2014, the remaining term of the options is 1.42 years, and 3,400,000 options are available for future grants under the 2012 Plan. All options are fully vested as of March 31, 2014 and no future expense related to these options is anticipated.

(12)

Note 8 – Income Taxes

Deferred income taxes reflect the net tax effects of operating loss and tax credit carry forwards and temporary differences between carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Due to the uncertainty of the Company’s ability to realize the benefit of the deferred tax assets, the deferred tax assets are fully offset by a valuation allowance at March 31, 2014 and December 31, 2013.

As of March 31, 2014, the Company had a tax net operating loss carry forward of approximately $385,000. Any unused portion of this carry forward expires in 2030. Utilization of this loss may be limited in the event of an ownership change pursuant to IRS Section 382.

Note 9 – Commitments and Contingencies

The Company is not a party to any litigation and, to its knowledge, no action, suit or proceeding has been threatened against the Company.

Effective June 1, 2013, the Company began leasing office space in Detroit, Michigan. The lease covers approximately 1,722 square feet is for two years with monthly rent of $1,950 for the first year and $2,010 for the second year. The Company leased the space for corporate offices as well as a call center for marketing the Company’s directory business. In November 2013, the Company was notified that the landlord was delinquent in their obligations to the mortgage holder of the building where the Company is leasing its office space. Rent expense for the three months ended March 31, 2014 and 2013 was $0 and $5,437, respectively.

In January 2014, due to the uncertainty of the Company’s lease in Detroit, Michigan, the Company decided to relocate its administrative offices to West Palm Beach, Florida. Effective April 1, 2014, the Company has entered into a rent sharing agreement for the use of 1,300 square feet with a company controlled by the Company’s CFO. The Company has agreed to pay $750 per month for the space.

(13)

Other Agreements

Our business agreements consist primarily of banking ISO agreements and technology licensing agreements. Banking agreements are typically agreements with merchant banks which provide all direct relationships with the credit card issuing banks, PCI compliant gateways for our merchant processing clients and administrative functions. These agreements typically involve a split of the fees received between the banks and the Company based on interchange rate, agent commissions, or a fixed fee per transaction. Licensing agreements are infrastructure in nature and establish the connection to the end user that enables the Company to deliver and collect payment for the transacted media content or service application. Licensing agreements typically involve a split of the fees received between the technology provider, carriers and the Company.

On August 1, 2012 the Company entered into a series of agreements with Payventures, LLC (“PV”) and Payventures Tech, LLC (“PVTECH”). PV operates a business of promoting merchant services offered by certain banks, including credit and debit card transaction processing and network services (“Merchant Services”) to merchants. Pursuant to an Assignment Agreement (“PAA”) between PV and the Company PV assigned fifty percent (50%) of PV’s rights to receive residual payments from certain Assigned Customer(s), in exchange for five hundred thousand (500,000) shares of the Company’s restricted common stock. Thetermofthe Assignment Agreement commencesontheEffectiveDateand shallcontinueforaperiodof one(1)yearafter whichit shall renew for successive one year terms automatically, unless terminated in accordance with theterms thereof.Either partyhas the right to terminate this Agreement at the end ofthe then current Term, upon thirty (30) days prior written notice to the other party. PV may terminate this Agreementatanytime on thirty (30) days written notice to the Company provided however, that ifsuch termination iswithout default or other material causeby the Company, then PV shall continue to pay the referral fees contemplated therein despite such termination, subject to the other provisions thereof that survive termination. In addition, PVmay terminate the assignment of the Assigned Customer, andany obligation topay the share of the Assigned Customer residual to the Company, upon thirty (30) daysprior notice to the Company. PV may terminate the assignment of the Assigned Customer and substitute one or more comparable Assigned Customers upon thirty (30)days prior notice to the Company. PV shall not berequiredto replace an Assigned Customer if such Assigned Customer terminates its merchant accountwithPV.

Effective October 1, 2012, PV and the Company entered into the First Amendment to Assignment Agreement (the “Amendment”). The Amendment replaces the assignment to the Company of 50% of PV’s residuals from the initial Assigned Customer to the assignment of 30% of PV’s residual payments received from a newly Assigned Customer, and such account shall henceforth be the Assigned Customer under the Assignment Agreement.

PV and the Company also entered into a Consulting Agreement, whereby PV will provide services to the Company, including; coordination of mobile messaging services, customer contact, customer assistance services and merchant acquisition and processing services. PV will be compensated at their standard hourly rate for such services. Thetermofthe Consulting Agreementcommences onthe EffectiveDateandshall continueforaperiodofone(1)year,afterwhich it shallrenew for successive one yearterms automatically, unless terminated inaccordance with theterms thereof. EitherParty hereto has the rightto terminatethe Consulting Agreement at anytime on thirty (30) days written notice. Also on August 1, 2012, PV and the Company executed an Agent Referral Agreement, whereby PV will compensate the Company for any customer referred to PV by the Company that subsequently utilizes PV’s Merchant Services. The term of the Agent Referral Agreement is for two years and automatically renews for each year thereafter (the “Term”) unless 60 days prior written notice is given by either party.

PVTECH and the Company entered into a Hosted Platform License & Services Agreement (“HPLSA”) whereby PVTECH will provide the Company access to their hosted ecommerce and processing platform products, as well as related services and support. Pursuant to the terms of the agreement, the Company will pay PVTECH a monthly licensing fee of $2,500 and a transaction fee of $0.07 per transaction, that beginning in April 2013, has a minimum transaction fee of $2,500 per month. Accordingly the Company has recorded, as part of cost of sales, $7,500 and $22,500 for the hosting fees for the three months ended March 31, 2014 and 2013, respectively, and $7,500 and $0, respectively, for the minimum transaction fees for the three months ended March 31, 2014 and 2013. Thetermofthe HPSLA shallbefor one (1) year, with automatic renewals for successive one (1)yearterms thereafter(eacha"RenewalTerm")until eitherpartygiveswrittennoticetoterminatethe HPLSAno less than three (3)calendarmonths priortothe commencementof a Renewal Term. Either partymay terminate the HPLSA: (a) upon a materialbreach by theother party if such breach is not curedwithin thirty (30) days following written notice to the breaching party; or (b) where theotherparty is subject to afiled bankruptcy petitionorformal insolvency proceeding that is not dismissedwithin thirty (30) days.

On August 7, 2012, the Company entered into a Client Agreement with 3Cinteractive, LLC. (“3Ci”). 3Ci will make available to the Company their “Switchblade Platform”. The Switchblade Platform enables users to send and receive SMS messages directly to and from US Mobile Operator subscribers. The service includes, web-based, API and file based interfaces to facilitate interactions between the Company and the Company’s clients. The platform provides full service SMS services including but not limited to the ability to create and manage interactive workflows, keyboard campaigns, text –to-screen, immediate or schedules broadcasts, post notification services, dynamic group management, external API access, mobile configuration and reporting. Pursuant to the agreement, the Company incurred a $2,500 set-up fee, and will be charged monthly, beginning one month from the billing activation date. The initial three months were $1,500, $2,000 and $2,500 respectively, and beginning in the fourth month from billing activation, the Company will incur a monthly fee of $3,000 as well $1,100 for our vanity short code (800 Commerce). The Company has received a letter of default from 3Ci regarding past amounts due of $18,500. The Company, through an agreement with Interactive MD, LLC (“iMD”) plans to market iMD’s telehealth services to consumers and employers. Our plan is to allow consumers and employers via a link from the my800doctor.com website to be able purchase various types of monthly memberships from iMD. If successful, 800 Commerce would receive a referral fee of $10 from iMD per member per month (“PMPM”) via the affiliate agreement, irrespective of the type of membership. 

(14)

Note 10 – Going Concern

The accompanying financial statements have been prepared assuming the Company will continue as a going concern. As of March 31, 2014, the Company had an accumulated deficit of approximately $1,532,719. These conditions raise substantial doubt about the Company's ability to continue as a going concern.The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Management’s Plans

The Company generates revenue from our marketing of credit processing services by way of fees we receive from merchant payment processing service providers on whose behalf we broker their processing services. On August 1, 2012, the Company began to receive additional revenue pursuant to a processing service provider’s assignment to us of a portion of its fee income under one of its service contracts in exchange for our issuance of 500,000 shares of our common shares. During the three months ended March 30, 2014, the Company also sold 50,000 shares of MediSwipe common stock it owned and has realized proceeds of approximately $16,554 from the sales.

The Company intends to begin marketing of the on-line portals and mobile applications that it has developed, offering directories of professional service providers. The Company has completed its’ initial on-line portal and mobile application dedicated to a directory of medical doctors, however we have not yet begun revenue producing by way of our medical directory. We expect to commence the marketing of our medical directory in the second quarter of 2014, and hope to commence receipt of revenue from the marketing of our medical directory during 2014. The Company has also completed the development of its second on-line portal and mobile application; a directory of lawyers.

(15)

Item 2. Management’s Discussion and Analysis or Plan of Operation

The following is management’s discussion and analysis of certain significant factors that have affected our financial position and operating results during the periods included in the accompanying consolidated financial statements, as well as information relating to the plans of our current management. This report includes forward-looking statements. Generally, the words “believes,” “anticipates,” “may,” “will,” “should,” “expect,” “intend,” “estimate,” “continue,” and similar expressions or the negative thereof or comparable terminology are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, including the matters set forth in this report or other reports or documents we file with the Securities and Exchange Commission from time to time, which could cause actual results or outcomes to differ materially from those projected. Undue reliance should not be placed on these forward-looking statements which speak only as of the date hereof. We undertake no obligation to update these forward-looking statements.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the audited consolidated financial statements and notes thereto for the years ended December 31, 2013 and 2012 filed with the SEC on April 11, 2014.

The independent auditor’s reports on our financial statements for the years ended December 31, 2013 and 2012 includes a “going concern” explanatory paragraph that describes substantial doubt about our ability to continue as a going concern. Management’s plans in regard to the factors prompting the explanatory paragraph are discussed below and also in Note 11 to the condensed financial statements filed herein.

Restatement of previously issued financial statements

The financial statements for the three months ended March 31, 2013 have been restated to amortize a portion of the fair value of common stock issued pursuant to the Assignment Agreement, which was previously expensed during 2012.

The restatement adjustments did not affect the statements of cash flows for the three months ended March 31, 2013 balance sheet with the exception of the decrease in retained deficit of $41,667, an increase in the amortization of $31,250 and a decrease of deferred equity consideration of $41,667. All related amounts have been restated as appropriate within these financial statements.

(a) Liquidity and Capital Resources

For the three months ended March 31, 2014, net cash used in operating activities was $25,221 compared to $27,397 for the three months ended March 31, 2013. The company had a net loss $22,445 for the three months ended March 31, 2014 compared to a net loss of $138,727 for the three months ended March 31, 2013. The net loss for the three months ended March 31, 2014 was impacted by the gain on sale of marketable securities and the changes in operating assets and liabilities. Negative cash flows in 2013 were due primarily to the net loss, offset by non-cash expenses related to amortization of deferred equity consideration for customer acquisition costs of $31,250 as a result of the issuance of 500,000 shares of the Company’s common stock pursuant to the initial one year term of the Assignment Agreement, amortization of the initial discount of $12,329 on the convertible note and by the non-cash stock based compensation of $75,500.

During the three months ended March 31, 2014, net cash provided by investing activities was $16,554 as a result of $16,554 received from the sale of marketable securities. Net cash used in investing activities was $1,929 for the three months ended March 31, 2013, due to the purchase of computer equipment.

During the three months ended March 31, 2014, net cash provided by financing activities was $14,150, compared to net cash provided by financing activities of $1,701 for the three months ended March 31, 2013. The 2014 amount was comprised of a repayment of $7,000 on the convertible note and increases of $21,150 in amounts due shareholders for services provided. The 2013 financing activity was the result of increases of $1,701 in amounts due shareholders for services provided.

For the three months ended March 31, 2014, cash and cash equivalents increased by $5,483 compared to a decrease of $27,625 for the three months ended March 31, 2013. Ending cash and cash equivalents at March 31, 2014 was $9,395 compared to $12,993 at March 31, 2013.

The Company has limited cash and cash equivalents on hand. The Company maintains its’ daily operations and capital needs through revenue from our marketing of credit processing services by way of fees we receive from merchant payment processing service providers on whose behalf we broker their processing services, as well as from the sale of marketable securities the Company owns. During the three months ended March 31, 2014, the Company sold 50,000 shares of MediSwipe common stock it owned and realized proceeds of approximately $16,554 from the sales.

The Company intends to engage in the development and operation of on-line portals and mobile applications offering directories of professional service providers. The Company has completed its’ initial on-line portal and mobile application dedicated to a directory of medical doctors, however we have not yet begun revenue producing by way of our medical directory. We commenced the initial marketing of our medical directory in September 2013, and hope to commence receipt of revenue from the marketing of our medical directory in the second or third quarter of 2014. The Company is preparing to launch its second on-line portal and mobile application; a directory of lawyers.

We will need to raise funds to continue to be able to support our operating expenses and to meet our other obligations as they become due. Sources available to us that we may utilize include the sale of unsecured convertible debentures from unaffiliated investors which may cause dilution to our stockholders. The company expects to increase sales of additional products over the course of this fiscal year.

(16)

(b) Results of Operations

Three months ended March 31, 2014 vs. March 31, 2013

Revenues

The Company had revenues for the three months ended March 31, 2014 of $90,448 compared to $93,812 for the three months ended March 31, 2013.

All of our revenue from inception through March 31, 2014, other than the revenue under the Assignment Agreement, has been derived from our marketing of credit card processing services on behalf of merchant payment processing service providers. We have entered into agent referral agreements with merchant payment processing service providers, including Payventures, LLC, and FrontStream Payments, Inc. (“FrontStream”) pursuant to which we receive a commission, based on a percentage of the net revenue received by the payment processor from customers we introduced to them. The Company received revenue of $1,013 from FrontStream for the three months ended March 31, 2014 compared to $3,787 for the three months ended March 31, 2013. The Company’s agreement with FrontStream (formerly Direct Technologies, LLC) was entered into on July 31, 2009 with a three (3) year term and automatically renews for successive one year terms, unless terminated by either party pursuant to the terms of the agreement. The Company receives an amount equal to 70% of the Residual for the previous month's activity, on or about the 25^th day of the next month.

Costs of Revenues

For the three months ended March 31, 2014, cost of revenues was $89,607. This expense was comprised of costs associated with a Consulting Agreement and Hosted License Fee whereby services provided to the Company, including: coordination of mobile messaging services, customer contact, customer assistance services and merchant acquisition and processing services. Pursuant to the Consulting Agreement, the consultant is compensated at standard hourly rates for such services. The costs for the three ended March 31, 2014 include $30,519 for merchant acquiring and processing services, $23,988 for mobile messaging services, $17,100 for customer contact and customer assistant services, $7,500 for hosted license fees and $7,500 for minimum transaction fees.

For the three months ended March 31, 2013, cost of revenues was $113,253. This expense was comprised of costs associated with a Consulting Agreement and Hosted License Fee whereby services provided to the Company, including: coordination of mobile messaging services, customer contact, customer assistance services and merchant acquisition and processing services. Pursuant to the Consulting Agreement, the consultant is compensated at standard hourly rates for such services. The costs for the three ended March 31, 2013 include $30,566 for merchant acquiring and processing services, $26,362 for mobile messaging services, $17,575 for customer contact and customer assistant services and $7,500 for hosted license fees. Also included in cost of sales for the three months ended March 31, 2013, was amortization of deferred equity consideration for customer acquisition costs of $31,250 as a result of the issuance of 500,000 shares of the Company’s common stock pursuant to the initial one year term of the Assignment Agreement.

(17)

Operating Expenses

Operating expenses were $30,340 for the three months ended March 31, 2014 compared to $120,311 for the three months ended March 31, 2013. The decrease of $89,971 for the three months ended March 31, 2014, was due primarily to a decrease in stock compensation expense of $75,500. Additionally for the three months ended March 31, 2014 there were salaries and management fees of $22,500 compared to $14,803 (excluding stock-based compensation)for the three months ended March 31, 2013. We expect an increase in overall expenses during 2014 due to the additional expenses incurred as a result of becoming a publicly traded company in the United States. At the present time, we do not have any agreements or plans to issue additional shares of common stock for services, however as an early stage company, and in consideration of the available cash we may have on hand in the future, we may decide to issue additional shares of stock, if the Board of Directors feel it is necessary to, among other items, attract and/or maintain qualified and competent management. The total amount of stock-based compensation expense ultimately is based on the number of awards that actually vest and fluctuates as a result of performance criteria, as well as the vesting period of all stock based awards. Accordingly, the amount of compensation expense recognized during any fiscal year may not be representative of future stock-based compensation expense. In accordance with ASC Topic 718, Compensation - Stock Compensation (ASC Topic 718), compensation costs for performance based awards are recognized over the requisite service period if it is probable that the performance goal will be satisfied. We use our best judgment to determine probability of achieving the performance goals in each reporting period and recognize compensation costs based on the number of shares that are expected to vest.

Other Income (Expense)

Other income for the three months ended March 31, 2014 was $7,054 compared to other income of $1,025 for the three months ended March 31, 2013. The Company recorded a gain on sale of marketable securities of $7,054 for the current period.

Other income for the three months ended March 31, 2013 included interest expense of $13,329 comprised of $12,329 related to the amortization of the initial discount on convertible promissory notes and $1,000 for the interest expense on the face value of the notes. Also included for the three months ended March 31, 2013 was $20,018 for the fair value change in the derivative associated with convertible promissory notes. The Company also recorded a gain on sale of marketable securities of $3,174 for the 2013 period.

Off Balance Sheet Arrangements

None

 Critical Accounting Policies

See Note 2 to the condensed financial statements included herein.

(18)

Item 3.  Quantitative and Qualitative Disclosures about Market Risk

Not applicable to smaller reporting companies.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed in our filings under the Exchange Act is recorded, processed, summarized and reported within the periods specified in the rules and forms of the SEC. This information is accumulated to allow our management to make timely decisions regarding required disclosure. Our President, who serves as our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report and he determined that our disclosure controls and procedures were not effective due to a control deficiency. During the period we did not have additional personnel to allow segregation of duties to ensure the completeness or accuracy of our information. Due to the size and operations of the Company, we are unable to remediate this deficiency until we acquire or merge with another company.

Changes in Internal Control over Financial Reporting

During the quarter ended March 31, 2014, there were no changes in the Company's internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.

Part II. Other Information

Item 1. Legal Proceedings

None.

Item 1A. Risk Factors

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Act of 1934 and are not required to provide the information under this item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None

(19)

Item 6. Exhibits and Reports on Form 8-K

(a) Exhibit index

31.1 Certification of Chief Executive Officer, and Director Pursuant to Section 302 of the Sarbanes-Oxley Act.

31.2 Certification of Chief Financial Officer, and Director Pursuant to Section 906 of the Sarbanes-Oxley Act.

32.1 Certification of Chief Executive Officer, and Director Pursuant to Section 302 of the Sarbanes-Oxley Act.

32.2 Certification of Chief Financial Officer, and Director Pursuant to Section 906 of the Sarbanes-Oxley Act.

(20)

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: May 20, 2014

800 COMMERCE, INC.

By: /s/ B. Michael Friedman

B. Michael Friedman

President and Director

(Principal Executive Officer)

(21)

EX-31.1

EXHIBIT 31.1

CERTIFICATION PURSUANT TO RULE 13A-14 OR 15D-14 OF THE SECURITIES

EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, B. Michael Friedman, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of 800 Commerce, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining internal disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f))for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

c. Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report my conclusion about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

Date: May 20, 2014	/s/ B. Michael Friedman
	B. Michael Friedman
	Principal Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION PURSUANT TO RULE 13A-14 OR 15D-14 OF THE SECURITIES

EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Barry S. Hollander, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of 800 Commerce, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining internal disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f))for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

c. Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report my conclusion about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

Date: May 20, 2014	/s/ Barry S. Hollander
	Barry S. Hollander
	Principal Accounting Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of 800 Commerce, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 20134as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, B. Michael Friedman, Principal Executive Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company, as of, and for the periods presented in the Report.

/s/ B. Michael Friedman          

B. Michael Friedman

Principal Executive Officer

May 20, 2014

A signed original of this written statement required by Section 906 has been provided to 800 Commerce, Inc. and will be retained by 800 Commerce, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of 800 Commerce, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Barry S. Hollander, Principal Accounting Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company, as of, and for the periods presented in the Report.

/s/ Barry S. Hollander            

Barry S. Hollander

Principal Accounting Officer

May 20, 2014

A signed original of this written statement required by Section 906 has been provided to 800 Commerce, Inc. and will be retained by 800 Commerce, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

4 SALES CONCENTRATION AND CONCENTRATION OF CREDIT RISK (Details Narrative) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Concentration Risks, Types, No Concentration Percentage [Abstract]
Amount insured by FDIC on account balances	$ 250,000
Percentage of revenues received	0.99	0.96
Accounts receivable from same merchant service provider	$ 29,723
Percentage of accounts receivable	0.97

XML

4 SALES CONCENTRATION AND CONCENTRATION OF CREDIT RISK

3 Months Ended

Mar. 31, 2014

Concentration Risks, Types, No Concentration Percentage [Abstract]

SALES CONCENTRATION AND CONCENTRATION OF CREDIT RISK

Note 4 – Sales Concentration and Concentration of Credit Risk

Cash

Financial   instruments   that   potentially   subject   the   Company to concentrations of credit risk consist principally of cash. The Company maintains cash balances at one financial institution, which is insured by the Federal Deposit Insurance Corporation (“FDIC”). The FDIC insured institution insures up to $250,000 on account balances. The amounts that are not insured by FDIC limitations are held in short-term securities. The Company has not experienced any losses in such accounts.

Sales

For the three months ended March 31, 2014 and 2013, approximately 99% and 96%, respectively, of the Company’s revenues for each period, were received from one merchant service provider, pursuant to an Assignment Agreement (see Note 9). As of March 31, 2014, the Company had $29,723 (97% of accounts receivable) in accounts receivable from the same merchant service provider. The Company relies on a few processors to provide, on a non-exclusive basis, transaction processing and transmittal, transaction authorization and data capture, and access to various reporting tools.

XML

8 INCOME TAXES (Details Narrative) (USD $)	Mar. 31, 2014
Income Tax Disclosure [Abstract]
Tax net operating loss carry forward	$ 385,000

XML

7 STOCK HOLDER'S EQUITY (DEFICIENCY) (Details Narrative) (USD $)	Mar. 31, 2014	Aug. 01, 2012
Stockholders' Equity:
Non-qualified stock option to purchase share of common stock		800,000
Exercise price		$ 0.30
Number of options immediately vested		200,000
Additional number of options vested		50,000
Number of options availeable for future grant	3,400,000

XML

9 COMMITMENTS AND CONTINGENCIES (Details Narrative) (USD $)	1 Months Ended			3 Months Ended		4 Months Ended	9 Months Ended	10 Months Ended	12 Months Ended			21 Months Ended	24 Months Ended
	Nov. 06, 2012	Oct. 06, 2012	Sep. 06, 2012	Mar. 31, 2014	Mar. 31, 2013	Jul. 31, 2013	Dec. 31, 2014 sqft	Jul. 31, 2013	May 31, 2015 sqft	May 31, 2014 sqft	Jul. 31, 2013	Aug. 06, 2014	Aug. 06, 2014
Monthly rent							$ 750		$ 2,010	$ 1,950
Rental expenses					5,437
Office space							1,300		1,722	1,722
Stock issued per assignment agreement											500,000
Percentage of revenue assigned								0.30			0.50
Monthly licensing fees	2,500	2,000	1,500								2,500	3,000
Transaction fee per transaction											0.07
Minimum montly transaction fee						2,500
Hosting fees				7,500	22,500
Minimum transaction fees				7,500
Initial set up fee													2,500
Amount in default					18,500							1,100
Income from referral per month per member				$ 10

XML

10 GOING CONCERN (Details Narrative) (USD $)	Mar. 31, 2014	Aug. 01, 2012
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ 1,532,719
Service contracts in exchange for issuance of common shares		500,000
Shares sold		50,000
Cash received		$ 16,554

XML

3 RECENT ACCOUNTING PRONOUNCEMENTS

3 Months Ended

Mar. 31, 2014

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

RECENT ACCOUNTING PRONOUNCEMENTS

Note 3 – Recent Accounting Pronouncements

Accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption.

XML

Balance Sheets (USD $)	Mar. 31, 2014	Dec. 31, 2013
Current Assets:
Cash and cash equivalents	$ 9,395	$ 3,912
Accounts receivable	30,606	29,159
Prepaid expenses	1,500
Marketable securities	263,400	72,150
Security deposit	700
Total current assets	305,601	105,221
Patents pending	33,950	33,950
Property and equipment, net	2,413	2,512
Total assets	341,964	141,683
Current Liabilities:
Accounts payable and accrued expenses	84,523	76,697
Due to stockholder	195,558	174,408
Convertible promssory note		7,000
Derivative liability		6,373
Total current liabilities	280,081	264,478
Stockholders' Equity:
Preferred stock, $0.001 par value; 10,000,000 shares authorized, none issued
Common stock, $.001 par value; 90,000,000 shares authorized; 19,950,000 shares issued and outstanding	19,950	19,950
Additional paid-in capital	1,425,252	1,418,879
Accumulated comprehensive income (loss)	149,400	(51,350)
Accumulated deficit	(1,532,719)	(1,510,274)
Total stockholders' equity	61,883	(122,795)
Total liabilities and stockholders' equity	$ 341,964	$ 141,683

XML

1 ORGANIZATION

3 Months Ended

Mar. 31, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

ORGANIZATION

Note 1 - Organization

Business

800 Commerce, Inc. (the “Company” or “800 Commerce”) was formed in the State of Florida on February 10, 2010. The Company was founded for the purpose of marketing credit card processing services on behalf of merchant payment processing service providers. The Company commenced revenue producing activities based on the marketing of credit processing services in March 2010. The Company generates revenue from the marketing of credit processing services by way of fees received from merchant payment processing service providers on whose behalf the Company brokers their processing services. On August 1, 2012, the Company began to receive additional revenue pursuant to a processing service provider’s assignment to the Company of a portion of its fee income under one of its service contracts in exchange for the issuance of 500,000 shares of our common stock.

In addition to marketing credit card processing services, the Company also has developed on-line portals and mobile applications offering directories of professional service providers. The Company has completed its’ initial on-line portal and mobile application dedicated to a directory of medical doctors, however the Company has not commenced revenue producing operations by way of the medical directory. The Company expects to re-launch the marketing of the medical directory in the second quarter of 2014, and hopes to commence receipt of revenue from the marketing of the medical directory in the third quarter of 2014.

On August 9, 2013, the Securities and Exchange Commission (the “SEC”) declared effective the Company’s Registration Statement on Form S-1/A, whereby the Company has registered the 6,000,000 shares of common stock owned by Mediswipe. Mediswipe distributed the 6,000,000 shares of common stock to their shareholders of record as of September 3, 2013. The shares were distributed on September 4, 2013.

In September 2013, the Company engaged a broker dealer, who has filed a Form 211 Application with the Financial Industry Regulatory Authority (“FINRA”) in order to obtain a symbol for quotation. The broker dealer is working with FINRA’s staff’s requests of the broker dealer in order to continue the review process. The Company and its counsel are closely monitoring the broker dealer’s response to FINRA. Pursuant to the SEC Rule 15C2-11, only the broker dealer can communicate with FINRA regarding this process.

XML

7 STOCK HOLDER'S EQUITY Summary of the activity of options (Details) (USD $)	Mar. 31, 2014
Stockholders' Equity:
Options Granted	1,600,000
Options Outstanding	1,600,000
Options exercisable	1,600,000
Weighted Average exercise price	$ 0.30
Weighted Average fair value	$ 0.21
Weighted Average exercise price - exercisable	$ 0.30
Weighted Average fair value - exercisable	$ 0.21

XML

2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) (USD $)	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]
Retained deficit	$ 41,667
Increase in the amortization	31,250
Increase of deferred equity	41,667
Dilutive securities	$ 1,600,000

XML

2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

3 Months Ended

Mar. 31, 2014

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Note 2 - Summary of Significant Accounting Policies

Basis of Presentation

The accompanying condensed financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments necessary to present the financial position, results of operations and cash flows for the stated periods have been made. Except as described below, these adjustments consist only of normal and recurring adjustments. Certain information and note disclosures normally included in the Company’s annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. These condensed financial statements should be read in conjunction with a reading of the Company’s consolidated financial statements and notes thereto included in the Company’s Form 10-K annual report filed with the Securities and Exchange Commission (SEC) on April 11, 2014. Interim results of operations for the three months ended March 31, 2014 are not necessarily indicative of future results for the full year. Certain amounts from the 2013 period have been reclassified to conform to the presentation used in the current period.

Restatement

The financial statements for the three months ended March 31, 2013 have been restated to amortize a portion of the fair value of common stock issued pursuant to the Assignment Agreement, which was previously expensed during 2012.

The following tables present the effects of the restatement adjustments on the affected line items in the previously reported statement of operations for the three months ended March 31, 2013. The restatement adjustments did not affect the statements of cash flows for the three months ended March 31, 2013 balance sheet with the exception of the decrease in retained deficit of $41,667, an increase in the amortization of $31,250 and a decrease of deferred equity consideration of $41,667. All related amounts have been restated as appropriate within these financial statements.

Three months ended March 31, 2013	As reported		Adjustments		Restated
Costs of revenues	$	82,003	$	31,250	$	113,253
Gross profit (loss)		11,809		(31,250)		(19,441)
Operating loss		(108,502)		(31,250)		(139,752)
Net loss		(107,477)		(31,250)		(138,727)
Comprehensive income		235,523		(31,250)		206,173
Net loss per share	$	(0.00)	$	(0.01)	$	(0.01)

Emerging Growth Company

We qualify as an “emerging growth company” under the 2012 JOBS Act. Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. As an emerging growth company, we can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of the benefits of this extended transition period.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents.

Accounts Receivable

The Company records accounts receivable from amounts due from its processors. The Company charges certain merchants for processing services at a bundled rate based on a percentage of the dollar amount of each transaction and, in some instances, additional fees are charged for each transaction. The Company charges other merchant customers a flat fee per transaction, and may also charge miscellaneous fees to customers, including fees for returns, monthly minimums, and other miscellaneous services. All the charges and collections thereon flow through processors who then remit the fee due the Company within the month following the actual charges.

Marketable Securities

The Company classifies its marketable securities as available-for-sale securities, which are carried at their fair value based on the quoted market prices of the securities with unrealized gains and losses, net of deferred income taxes, reported as accumulated other comprehensive income (loss), a separate component of stockholders’ equity. Realized gains and losses on available-for-sale securities are included in net earnings in the period earned or incurred.

Patents

The Company capitalizes patent pending acquisition costs, legal fees and filing costs associated with the development and filing of its patents.  Patents are generally amortized over an estimated useful life of 15 years using the straight-line method beginning on the issue date.  No amortization expense was recorded during the three months ended March 31, 2014 and 2013, as the Company’s patents are still pending as of March 31, 2014.

Revenue Recognition

The Company recognizes revenue in accordance with FASB ASC 605, Revenue Recognition. ASC 605 requires that four basic criteria are met (1) persuasive evidence of an arrangement exists, (2) delivery of products and services has occurred, (3) the fee is fixed or determinable and (4) collectability is reasonably assured. The Company recognizes revenue during the month in which commissions are earned.

Fair Value of Financial Instruments

Fair value measurements are determined under a three-level hierarchy for fair value measurements that prioritizes the inputs to valuation techniques used to measure fair value, distinguishing between market participant assumptions developed based on market data obtained from sources independent of the reporting entity (“observable inputs”) and the reporting entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (“unobservable inputs”). Fair value is the price that would be received to sell an asset or would be paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date. In determining fair value, the Company primarily uses prices and other relevant information generated by market transactions involving identical or comparable assets (“market approach”). The Company also considers the impact of a significant decrease in volume and level of activity for an asset or liability when compared with normal activity to identify transactions that are not orderly.

The highest priority is given to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Securities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

The three hierarchy levels are defined as follows:

Level 1 – Quoted prices in active markets that is unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2 – Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly;

Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

Credit risk adjustments are applied to reflect the Company’s own credit risk when valuing all liabilities measured at fair value. The methodology is consistent with that applied in developing counterparty credit risk adjustments, but incorporates the Company’s own credit risk as observed in the credit default swap market.

The Company's financial instruments consist primarily of marketable securities. Marketable securities are adjusted to fair value each balance sheet date, based on quoted prices; which are considered level 1 inputs (see Note 5). The estimated fair value is not necessarily indicative of the amounts the Company would realize in a current market exchange or from future earnings or cash flows.

The Company’s derivative liability resulting from the issuance of convertible debt is adjusted to fair value based on recent sales of the underlying common stock and the use of an option pricing model, which are consistent with level 3 inputs. See Note 6.

The following table represents the Company’s financial instruments that are measured at fair value on a recurring basis as of March 31, 2014 and December 31, 2013 for each fair value hierarchy level:

March 31, 2014	Derivative Liability		Marketable Securities		Total
Level I	$	—	$	263,400	$	263,400
Level II	$	—	$	—	$	—
Level III	$	—	$	—	$	—
December 31, 2013
Level I	$	—	$	72,150	$	72,150
Level II	$	—	$	—	$	—
Level III	$	6,373	$	—	$	6,373

The carrying amount of the Company’s accounts payable and accrued expenses, due to related parties and convertible debt approximate fair value to their short term.

Income Taxes

The Company accounts for income taxes in accordance with ASC 740-10, Income Taxes. The Company recognizes deferred tax assets and liabilities to reflect the estimated future tax effects, calculated at the tax rate expected to be in effect at the time of realization. The Company records a valuation allowance related to a deferred tax asset when it is more likely than not that some portion of the deferred tax asset will not be realized. Deferred tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates of the date of enactment.

ASC 740-10 prescribes a recognition threshold that a tax position is required to meet before being recognized in the financial statements and provides guidance on recognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition issues. The Company classifies interest and penalties as a component of interest and other expenses. To date, the Company has not been assessed, nor has the Company paid, any interest or penalties.

The Company measures and records uncertain tax positions by establishing a threshold for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Only tax positions meeting the more-likely-than-not recognition threshold at the effective date may be recognized or continue to be recognized. The Company’s tax years subsequent to 2010 remain subject to examination by federal and state tax jurisdictions.

Earnings (Loss) Per Share

The Company reports earnings (loss) per share in accordance with ASC 260, "Earnings per Share." Basic earnings (loss) per share is computed by dividing net income (loss), after deducting preferred stock dividends accumulated during the period, by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net income by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Potentially dilutive securities for the three months ended March 31, 2014 included options to purchase 1,600,000 shares of common stock, which were not included in the calculation of diluted loss per share because their impact was anti-dilutive.

Accounting for Stock-based Compensation 

The Company accounts for stock awards issued to non-employees in accordance with ASC 505-50, Equity-Based Payments to Non-Employees. The measurement date is the earlier of (1) the date at which a commitment for performance by the counterparty to earn the equity instruments is reached, or (2) the date at which the counterparty's performance is complete. Stock awards granted to non-employees are valued at their respective measurement dates based on the trading price of the Company’s common stock and recognized as expense during the period in which services are provided.

Comprehensive Income

The Company has adopted ASC Topic 220, "Comprehensive Income." This statement establishes standards for reporting comprehensive income and its components in a financial statement. Comprehensive income as defined includes all changes in equity (net assets) during a period from non-owner sources. Items included in the Company’s comprehensive loss consist of unrealized losses on available-for-sale securities.

XML

Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Statement of Financial Position [Abstract]
Preferred Stock, par value	$ 0.001	$ 0.001
Preferred Stock, shares authorized	10,000,000	10,000,000
Preferred Stock, shares issued	0	0
Preferred Stock, shares outstanding	0	0
Common Stock, shares authorized	90,000,000	90,000,000
Common Stock, shares issued	19,950,000	19,950,000

XML

2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2014

Accounting Policies [Abstract]

Restatement

Three months ended March 31, 2013	As reported		Adjustments		Restated
Costs of revenues	$	82,003	$	31,250	$	113,253
Gross profit (loss)		11,809		(31,250)		(19,441)
Operating loss		(108,502)		(31,250)		(139,752)
Net loss		(107,477)		(31,250)		(138,727)
Comprehensive income		235,523		(31,250)		206,173
Net loss per share	$	(0.00)	$	(0.01)	$	(0.01)

Company's financial instruments measured at fair value on recurring basis

March 31, 2014	Derivative Liability		Marketable Securities		Total
Level I	$	—	$	263,400	$	263,400
Level II	$	—	$	—	$	—
Level III	$	—	$	—	$	—
December 31, 2013
Level I	$	—	$	72,150	$	72,150
Level II	$	—	$	—	$	—
Level III	$	6,373	$	—	$	6,373

XML

Document and Entity Information (USD $)	3 Months Ended
	Mar. 31, 2014	May 19, 2014
Document And Entity Information
Entity Registrant Name	800 Commerce, Inc.
Entity Central Index Key	0001558465
Document Type	10-Q
Document Period End Date	Mar. 31, 2014
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float		$ 0
Entity Common Stock, Shares Outstanding		19,950,000
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2014

XML

5 MARKETABLE SECURITES (Tables)

3 Months Ended

Mar. 31, 2014

Marketable Securities [Abstract]

Marketable securities

	2014		2013
Historical cost	$114,000		$123,500
Unrealized gain (loss) included in accumulated  other comprehensive gain (loss)		149,400		(51,350	)
Net carrying value	$	263,400	$	72,150

XML

Statements of Operations (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Income Statement [Abstract]
Fee revenue, net	$ 90,448	$ 93,812
Cost of revenue	89,607	113,253
Gross profit	841	(19,441)
Operating expenses:
Salaries and management fees	22,500	90,303
Rent		5,437
Travel and entertainment		2,406
Transfer agent and filing fees	2,970	1,832
Professional and consulting fees	3,150	5,962
Software development and internet expenses	873	1,711
Other general and administrative	847	12,660
Total operating expenses	30,340	120,311
Operating loss	(29,499)	(139,752)
Other income (expense):
Interest expense		(13,329)
Change in fair market value of derivative liabilities		11,180
Gain on sale of marketable securities	7,054	3,174
Total other income, net	7,054	1,025
Net loss	(22,445)	(138,727)
Other Comprehensive gain (loss), net of tax:
Unrealized (loss) gain on marketable securities	207,804	348,074
Less reclassification adjustment for gains included in net loss	(7,054)	(3,174)
Other comprehensive (loss) gain	200,750	344,900
Comprehensive loss	$ 178,305	$ 206,173
Net loss per share	$ 0.00	$ (0.01)
Weighted average number of common shares outstanding Basic and diluted	19,950,000	19,050,000

XML

7 STOCK HOLDER'S EQUITY

3 Months Ended

Mar. 31, 2014

Stockholders' Equity:

COMMON STOCK

Note 7 – Stockholders’ Equity

Stock Options

Effective August 1, 2012 the Company adopted the 2012 Equity Incentive Plan (the “2012 Plan”) whereby the Company has reserved five million shares of common stock to be available for grants pursuant to the 2012 Plan.

Effective August 1, 2012, the Company entered into two Advisory Board Agreements (“ABA”) pursuant to which, the Company granted to each of Dr. James Canton and Mr. Scott Climes a non-qualified stock option to purchase 800,000 shares of common stock of the Company at an exercise price of $0.30 per share. The options were granted under the 2012 Plan and have a three year term. Mr. Climes is now a member of the board of directors of the Company and Dr. Canton the Chairman of the Board of Directors of the Company at the time (resigned January 15, 2014). Pursuant to each ABA, 200,000 options immediately vested and an additional 50,000 vest under each ABA at the end August 2012 and for the following eleven months, as long as Messrs. Climes and Canton remain as a director.

A summary of the activity of options for the three months ended March 31, 2014 is as follows:

	Options		Weighted-Average exercise price		Weighted- Average grant date fair value
Balance January 1, 2014		1,600,000	$	0.30	$	0.21
Options granted		—		—		—
Outstanding as of March 31, 2014		1,600,000		0.30		0.21
Exercisable as of March 31, 2014		1,600,000		0.30		0.21

As of March 31, 2014, the remaining term of the options is 1.42 years, and 3,400,000 options are available for future grants under the 2012 Plan. All options are fully vested as of March 31, 2014 and no future expense related to these options is anticipated.

XML

6 RELATED PARTY TRANSACTIONS

3 Months Ended

Mar. 31, 2014

Related Party Transactions [Abstract]

RELATED PARTY TRANSACTIONS

Note 6 – Related Party Transactions

Management Fees

During the three months ended March 31, 2014 and 2013 the Company expensed management fees of $13,500 and $3,003, respectively to or on behalf of the Company’s President, B. Michael Friedman, and $9,000 and $9,000, respectively, to the Company’s Chief Financial Officer, Barry Hollander. Effective August 1, 2012, the Company entered into two Advisory Board Agreements (“ABA”) pursuant to which, the Company granted to each of Dr. James Canton and Mr. Scott Climes a non-qualified stock option to purchase 800,000 shares of common stock of the Company at an exercise price of $0.30 per share. The options were granted under the 2012 Plan and have a three year term. Accordingly, for the three months ended March 31, 2013, the Company expensed $63,000 in stock compensation expense for options that vested during the period. Amounts due stockholders on the balance sheet as of March 31, 2014, and December 31, 2013 include Mr. Friedman $44,997(2014) and $32,847 (2013) and Mr. Canton $66,667 (2014 and 2013).

Amounts due Mediswipe, Inc.

As of December 31, 2012, Mediswipe, Inc, (“Mediswipe”) owned 6,000,000 shares of the Company’s common stock, representing approximately 32% of the Company’s outstanding common stock. Effective September 4, 2013, Mediswipe distributed the 6,000,000 shares of the Company’s common stock to their shareholders of record as of September 3, 2013 (see note 11). The Company and Mediswipe are commonly controlled due to common management and board members. The Company owes Mediswipe $83,895 and $74,895 as of March 31, 2014 and December 31, 2013, respectively, as a result of advances received from Mediswipe. These advances are non-interest bearing and are due on demand and are included in amounts due shareholders on the March 31, 2014, balance sheet herein.

Convertible Promissory Note

In May 2012, the Company entered into a note agreement with Mr. Climes, our Chief Executive Officer and a member of our board of directors, for the issuance of a convertible promissory note in the amount of $50,000 (the “Note”). Among other terms the Note was due one year from its issuance date, bears interest at 8% per annum, payable in cash or shares at the Conversion Price as defined herewith, and was convertible at a conversion price (the “Conversion Price”) for each share of common stock equal to 65% of the lowest closing bid price within five days of any conversion. Additionally, there are limitations on the holder’s right to convert whereby there cannot be any conversion that would cause the holders beneficial ownership to exceed 4.9% of the total issued and outstanding common stock of the Company. Upon the occurrence of an event of default, as defined in the Note, the Company was required to pay interest at 12% per annum and the holders may at their option declare the Note, together with accrued and unpaid interest, to be immediately due and payable. In addition, the Note provided for adjustments for dividends payable other than in shares of common stock, for reclassification, exchange or substitution of the common stock for another security or securities of the Company or pursuant to a reorganization, merger, consolidation, or sale of assets, where there is a change in control of the Company. During the year ended December 31, 2013, the Company repaid $43,000 of the Note. During the quarter ended March 31, 2014, the Company repaid the remainder of the Note due.

The Company determined that the conversion feature of the Note represented an embedded derivative since the Note was convertible into a variable number of shares upon conversion. Accordingly, the Note was not considered to be conventional debt under EITF 00-19 and the embedded conversion feature was required to be bifurcated from the debt host and accounted for as a derivative liability. Accordingly, the fair value of this derivative instrument was recorded as a liability on the balance sheet with the corresponding amount recorded as a discount to the Note. Such discount was accreted from the date of issuance to the maturity date of the Note. The change in the fair value of the derivative liability will be recorded in other income or expenses in the statement of operations at the end of each quarter, with the offset to the derivative liability on the balance sheet. The beneficial conversion feature included in the Note resulted in an initial debt discount of $50,000 and an initial loss on the valuation of derivative liabilities of $1,282 based on the initial fair value of the derivative liability of $51,282.

At December 31, 2012, the Company revalued the embedded derivative liability. For the period from issuance to December 31, 2012, the Company decreased the derivative liability of $51,282 by $11,282 resulting in a derivative liability of $40,000 at December 31, 2012. On the dates of repayment of $43,000 in 2013 of principal, the Company reclassed the fair value of related conversion feature, $25,329, to additional paid in capital. On the dates of repayment of $7,000 of principal, the Company reclassed the fair value of related conversion feature, $6,373, to additional paid in capital.

XML

1 ORGANIZATION (Details Narrative)	Aug. 01, 2012
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of shares issued in exchanged for service contracts	500,000
Common stock shares distributed by Mediswipe	6,000,000

XML

7 COMMON STOCK (Tables)

3 Months Ended

Mar. 31, 2014

Stockholders' Equity:

Summary of the activity of options

	Options		Weighted-Average exercise price		Weighted- Average grant date fair value
Balance January 1, 2014		1,600,000	$	0.30	$	0.21
Options granted		—		—		—
Outstanding as of March 31, 2014		1,600,000		0.30		0.21
Exercisable as of March 31, 2014		1,600,000		0.30		0.21

XML

10 GOING CONCERN

3 Months Ended

Mar. 31, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

GOING CONCERN

Note 10 – Going Concern

The accompanying financial statements have been prepared assuming the Company will continue as a going concern. As of March 31, 2014, the Company had an accumulated deficit of approximately $1,532,719. These conditions raise substantial doubt about the Company's ability to continue as a going concern.The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Management’s Plans

The Company generates revenue from our marketing of credit processing services by way of fees we receive from merchant payment processing service providers on whose behalf we broker their processing services. On August 1, 2012, the Company began to receive additional revenue pursuant to a processing service provider’s assignment to us of a portion of its fee income under one of its service contracts in exchange for our issuance of 500,000 shares of our common shares. During the three months ended March 30, 2014, the Company also sold 50,000 shares of MediSwipe common stock it owned and has realized proceeds of approximately $16,554 from the sales.

The Company intends to begin marketing of the on-line portals and mobile applications that it has developed, offering directories of professional service providers. The Company has completed its’ initial on-line portal and mobile application dedicated to a directory of medical doctors, however we have not yet begun revenue producing by way of our medical directory. We expect to commence the marketing of our medical directory in the second quarter of 2014, and hope to commence receipt of revenue from the marketing of our medical directory during 2014. The Company has also completed the development of its second on-line portal and mobile application; a directory of lawyers.

XML

8 INCOME TAXES

3 Months Ended

Mar. 31, 2014

Income Tax Disclosure [Abstract]

INCOME TAXES

Note 8 – Income Taxes

Deferred income taxes reflect the net tax effects of operating loss and tax credit carry forwards and temporary differences between carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Due to the uncertainty of the Company’s ability to realize the benefit of the deferred tax assets, the deferred tax assets are fully offset by a valuation allowance at March 31, 2014 and December 31, 2013.

As of March 31, 2014, the Company had a tax net operating loss carry forward of approximately $385,000. Any unused portion of this carry forward expires in 2030. Utilization of this loss may be limited in the event of an ownership change pursuant to IRS Section 382.

XML

9 COMMITMENTS AND CONTINGENCIES

3 Months Ended

Mar. 31, 2014

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

Note 9 – Commitments and Contingencies

The Company is not a party to any litigation and, to its knowledge, no action, suit or proceeding has been threatened against the Company.

Effective June 1, 2013, the Company began leasing office space in Detroit, Michigan. The lease covers approximately 1,722 square feet is for two years with monthly rent of $1,950 for the first year and $2,010 for the second year. The Company leased the space for corporate offices as well as a call center for marketing the Company’s directory business. In November 2013, the Company was notified that the landlord was delinquent in their obligations to the mortgage holder of the building where the Company is leasing its office space. Rent expense for the three months ended March 31, 2014 and 2013 was $0 and $5,437, respectively.

In January 2014, due to the uncertainty of the Company’s lease in Detroit, Michigan, the Company decided to relocate its administrative offices to West Palm Beach, Florida. Effective April 1, 2014, the Company has entered into a rent sharing agreement for the use of 1,300 square feet with a company controlled by the Company’s CFO. The Company has agreed to pay $750 per month for the space.

Other Agreements

Our business agreements consist primarily of banking ISO agreements and technology licensing agreements. Banking agreements are typically agreements with merchant banks which provide all direct relationships with the credit card issuing banks, PCI compliant gateways for our merchant processing clients and administrative functions. These agreements typically involve a split of the fees received between the banks and the Company based on interchange rate, agent commissions, or a fixed fee per transaction. Licensing agreements are infrastructure in nature and establish the connection to the end user that enables the Company to deliver and collect payment for the transacted media content or service application. Licensing agreements typically involve a split of the fees received between the technology provider, carriers and the Company.

On August 1, 2012 the Company entered into a series of agreements with Payventures, LLC (“PV”) and Payventures Tech, LLC (“PVTECH”). PV operates a business of promoting merchant services offered by certain banks, including credit and debit card transaction processing and network services (“Merchant Services”) to merchants. Pursuant to an Assignment Agreement (“PAA”) between PV and the Company PV assigned fifty percent (50%) of PV’s rights to receive residual payments from certain Assigned Customer(s), in exchange for five hundred thousand (500,000) shares of the Company’s restricted common stock. Thetermofthe Assignment Agreement commencesontheEffectiveDateand shallcontinueforaperiodof one(1)yearafter whichit shall renew for successive one year terms automatically, unless terminated in accordance with theterms thereof.Either partyhas the right to terminate this Agreement at the end ofthe then current Term, upon thirty (30) days prior written notice to the other party. PV may terminate this Agreementatanytime on thirty (30) days written notice to the Company provided however, that ifsuch termination iswithout default or other material causeby the Company, then PV shall continue to pay the referral fees contemplated therein despite such termination, subject to the other provisions thereof that survive termination. In addition, PVmay terminate the assignment of the Assigned Customer, andany obligation topay the share of the Assigned Customer residual to the Company, upon thirty (30) daysprior notice to the Company. PV may terminate the assignment of the Assigned Customer and substitute one or more comparable Assigned Customers upon thirty (30)days prior notice to the Company. PV shall not berequiredto replace an Assigned Customer if such Assigned Customer terminates its merchant accountwithPV.

Effective October 1, 2012, PV and the Company entered into the First Amendment to Assignment Agreement (the “Amendment”). The Amendment replaces the assignment to the Company of 50% of PV’s residuals from the initial Assigned Customer to the assignment of 30% of PV’s residual payments received from a newly Assigned Customer, and such account shall henceforth be the Assigned Customer under the Assignment Agreement.

PV and the Company also entered into a Consulting Agreement, whereby PV will provide services to the Company, including; coordination of mobile messaging services, customer contact, customer assistance services and merchant acquisition and processing services. PV will be compensated at their standard hourly rate for such services. Thetermofthe Consulting Agreementcommences onthe EffectiveDateandshall continueforaperiodofone(1)year,afterwhich it shallrenew for successive one yearterms automatically, unless terminated inaccordance with theterms thereof. EitherParty hereto has the rightto terminatethe Consulting Agreement at anytime on thirty (30) days written notice. Also on August 1, 2012, PV and the Company executed an Agent Referral Agreement, whereby PV will compensate the Company for any customer referred to PV by the Company that subsequently utilizes PV’s Merchant Services. The term of the Agent Referral Agreement is for two years and automatically renews for each year thereafter (the “Term”) unless 60 days prior written notice is given by either party.

PVTECH and the Company entered into a Hosted Platform License & Services Agreement (“HPLSA”) whereby PVTECH will provide the Company access to their hosted ecommerce and processing platform products, as well as related services and support. Pursuant to the terms of the agreement, the Company will pay PVTECH a monthly licensing fee of $2,500 and a transaction fee of $0.07 per transaction, that beginning in April 2013, has a minimum transaction fee of $2,500 per month. Accordingly the Company has recorded, as part of cost of sales, $7,500 and $22,500 for the hosting fees for the three months ended March 31, 2014 and 2013, respectively, and $7,500 and $0, respectively, for the minimum transaction fees for the three months ended March 31, 2014 and 2013. Thetermofthe HPSLA shallbefor one (1) year, with automatic renewals for successive one (1)yearterms thereafter(eacha"RenewalTerm")until eitherpartygiveswrittennoticetoterminatethe HPLSAno less than three (3)calendarmonths priortothe commencementof a Renewal Term. Either partymay terminate the HPLSA: (a) upon a materialbreach by theother party if such breach is not curedwithin thirty (30) days following written notice to the breaching party; or (b) where theotherparty is subject to afiled bankruptcy petitionorformal insolvency proceeding that is not dismissedwithin thirty (30) days.

On August 7, 2012, the Company entered into a Client Agreement with 3Cinteractive, LLC. (“3Ci”). 3Ci will make available to the Company their “Switchblade Platform”. The Switchblade Platform enables users to send and receive SMS messages directly to and from US Mobile Operator subscribers. The service includes, web-based, API and file based interfaces to facilitate interactions between the Company and the Company’s clients. The platform provides full service SMS services including but not limited to the ability to create and manage interactive workflows, keyboard campaigns, text –to-screen, immediate or schedules broadcasts, post notification services, dynamic group management, external API access, mobile configuration and reporting. Pursuant to the agreement, the Company incurred a $2,500 set-up fee, and will be charged monthly, beginning one month from the billing activation date. The initial three months were $1,500, $2,000 and $2,500 respectively, and beginning in the fourth month from billing activation, the Company will incur a monthly fee of $3,000 as well $1,100 for our vanity short code (800 Commerce). The Company has received a letter of default from 3Ci regarding past amounts due of $18,500. The Company, through an agreement with Interactive MD, LLC (“iMD”) plans to market iMD’s telehealth services to consumers and employers. Our plan is to allow consumers and employers via a link from the my800doctor.com website to be able purchase various types of monthly memberships from iMD. If successful, 800 Commerce would receive a referral fee of $10 from iMD per member per month (“PMPM”) via the affiliate agreement, irrespective of the type of membership. 

XML

2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

3 Months Ended

Mar. 31, 2014

Accounting Policies [Abstract]

BASIS OF PRESENTATION

Basis of Presentation

The accompanying condensed financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments necessary to present the financial position, results of operations and cash flows for the stated periods have been made. Except as described below, these adjustments consist only of normal and recurring adjustments. Certain information and note disclosures normally included in the Company’s annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. These condensed financial statements should be read in conjunction with a reading of the Company’s consolidated financial statements and notes thereto included in the Company’s Form 10-K annual report filed with the Securities and Exchange Commission (SEC) on April 11, 2014. Interim results of operations for the three months ended March 31, 2014 are not necessarily indicative of future results for the full year. Certain amounts from the 2013 period have been reclassified to conform to the presentation used in the current period.

RESTATEMENT

Restatement

The financial statements for the three months ended March 31, 2013 have been restated to amortize a portion of the fair value of common stock issued pursuant to the Assignment Agreement, which was previously expensed during 2012.

The following tables present the effects of the restatement adjustments on the affected line items in the previously reported statement of operations for the three months ended March 31, 2013. The restatement adjustments did not affect the statements of cash flows for the three months ended March 31, 2013 balance sheet with the exception of the decrease in retained deficit of $41,667, an increase in the amortization of $31,250 and a decrease of deferred equity consideration of $41,667. All related amounts have been restated as appropriate within these financial statements.

Three months ended March 31, 2013	As reported		Adjustments		Restated
Costs of revenues	$	82,003	$	31,250	$	113,253
Gross profit (loss)		11,809		(31,250)		(19,441)
Operating loss		(108,502)		(31,250)		(139,752)
Net loss		(107,477)		(31,250)		(138,727)
Comprehensive income		235,523		(31,250)		206,173
Net loss per share	$	(0.00)	$	(0.01)	$	(0.01)

EMERGING GROWTH COMPANY

Emerging Growth Company

We qualify as an “emerging growth company” under the 2012 JOBS Act. Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. As an emerging growth company, we can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of the benefits of this extended transition period.

USE OF ESTIMATES

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.

CASH AND CASH EQUIVALENTS

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents.

ACCOUNTS RECEIVABLE

Accounts Receivable

The Company records accounts receivable from amounts due from its processors. The Company charges certain merchants for processing services at a bundled rate based on a percentage of the dollar amount of each transaction and, in some instances, additional fees are charged for each transaction. The Company charges other merchant customers a flat fee per transaction, and may also charge miscellaneous fees to customers, including fees for returns, monthly minimums, and other miscellaneous services. All the charges and collections thereon flow through processors who then remit the fee due the Company within the month following the actual charges.

MARKETABLE SECURITIES

Marketable Securities

The Company classifies its marketable securities as available-for-sale securities, which are carried at their fair value based on the quoted market prices of the securities with unrealized gains and losses, net of deferred income taxes, reported as accumulated other comprehensive income (loss), a separate component of stockholders’ equity. Realized gains and losses on available-for-sale securities are included in net earnings in the period earned or incurred.

PATENTS

Patents

The Company capitalizes patent pending acquisition costs, legal fees and filing costs associated with the development and filing of its patents.  Patents are generally amortized over an estimated useful life of 15 years using the straight-line method beginning on the issue date.  No amortization expense was recorded during the three months ended March 31, 2014 and 2013, as the Company’s patents are still pending as of March 31, 2014.

REVENUE RECOGNITION

Revenue Recognition

The Company recognizes revenue in accordance with FASB ASC 605, Revenue Recognition. ASC 605 requires that four basic criteria are met (1) persuasive evidence of an arrangement exists, (2) delivery of products and services has occurred, (3) the fee is fixed or determinable and (4) collectability is reasonably assured. The Company recognizes revenue during the month in which commissions are earned.

FAIR VALUE OF FINANCIAL INSTRUMENTS

Fair Value of Financial Instruments

Fair value measurements are determined under a three-level hierarchy for fair value measurements that prioritizes the inputs to valuation techniques used to measure fair value, distinguishing between market participant assumptions developed based on market data obtained from sources independent of the reporting entity (“observable inputs”) and the reporting entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (“unobservable inputs”). Fair value is the price that would be received to sell an asset or would be paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date. In determining fair value, the Company primarily uses prices and other relevant information generated by market transactions involving identical or comparable assets (“market approach”). The Company also considers the impact of a significant decrease in volume and level of activity for an asset or liability when compared with normal activity to identify transactions that are not orderly.

The highest priority is given to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Securities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

The three hierarchy levels are defined as follows:

Level 1 – Quoted prices in active markets that is unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2 – Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly;

Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

Credit risk adjustments are applied to reflect the Company’s own credit risk when valuing all liabilities measured at fair value. The methodology is consistent with that applied in developing counterparty credit risk adjustments, but incorporates the Company’s own credit risk as observed in the credit default swap market.

The Company's financial instruments consist primarily of marketable securities. Marketable securities are adjusted to fair value each balance sheet date, based on quoted prices; which are considered level 1 inputs (see Note 5). The estimated fair value is not necessarily indicative of the amounts the Company would realize in a current market exchange or from future earnings or cash flows.

The Company’s derivative liability resulting from the issuance of convertible debt is adjusted to fair value based on recent sales of the underlying common stock and the use of an option pricing model, which are consistent with level 3 inputs. See Note 6.

The following table represents the Company’s financial instruments that are measured at fair value on a recurring basis as of March 31, 2014 and December 31, 2013 for each fair value hierarchy level:

March 31, 2014	Derivative Liability		Marketable Securities		Total
Level I	$	—	$	263,400	$	263,400
Level II	$	—	$	—	$	—
Level III	$	—	$	—	$	—
December 31, 2013
Level I	$	—	$	72,150	$	72,150
Level II	$	—	$	—	$	—
Level III	$	6,373	$	—	$	6,373

The carrying amount of the Company’s accounts payable and accrued expenses, due to related parties and convertible debt approximate fair value to their short term.

INCOME TAXES

Income Taxes

The Company accounts for income taxes in accordance with ASC 740-10, Income Taxes. The Company recognizes deferred tax assets and liabilities to reflect the estimated future tax effects, calculated at the tax rate expected to be in effect at the time of realization. The Company records a valuation allowance related to a deferred tax asset when it is more likely than not that some portion of the deferred tax asset will not be realized. Deferred tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates of the date of enactment.

ASC 740-10 prescribes a recognition threshold that a tax position is required to meet before being recognized in the financial statements and provides guidance on recognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition issues. The Company classifies interest and penalties as a component of interest and other expenses. To date, the Company has not been assessed, nor has the Company paid, any interest or penalties.

The Company measures and records uncertain tax positions by establishing a threshold for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Only tax positions meeting the more-likely-than-not recognition threshold at the effective date may be recognized or continue to be recognized. The Company’s tax years subsequent to 2010 remain subject to examination by federal and state tax jurisdictions.

EARNINGS (LOSS) PER SHARE

Earnings (Loss) Per Share

The Company reports earnings (loss) per share in accordance with ASC 260, "Earnings per Share." Basic earnings (loss) per share is computed by dividing net income (loss), after deducting preferred stock dividends accumulated during the period, by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net income by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Potentially dilutive securities for the three months ended March 31, 2014 included options to purchase 1,600,000 shares of common stock, which were not included in the calculation of diluted loss per share because their impact was anti-dilutive.

ACCOUNTING FOR STOCK-BASED COMPENSATION

Accounting for Stock-based Compensation 

The Company accounts for stock awards issued to non-employees in accordance with ASC 505-50, Equity-Based Payments to Non-Employees. The measurement date is the earlier of (1) the date at which a commitment for performance by the counterparty to earn the equity instruments is reached, or (2) the date at which the counterparty's performance is complete. Stock awards granted to non-employees are valued at their respective measurement dates based on the trading price of the Company’s common stock and recognized as expense during the period in which services are provided.

COMPREHENSIVE INCOME

Comprehensive Income

The Company has adopted ASC Topic 220, "Comprehensive Income." This statement establishes standards for reporting comprehensive income and its components in a financial statement. Comprehensive income as defined includes all changes in equity (net assets) during a period from non-owner sources. Items included in the Company’s comprehensive loss consist of unrealized losses on available-for-sale securities.

XML

5 MARKETABLE SECURITES - Marketable securities (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Marketable Securities [Abstract]
Historical cost	$ 114,000	$ 123,500
Unrealized losses included in accumulated other comprehensive income (loss)	149,400	(51,350)
Net carrying value	$ 263,400	$ 72,150

XML

5 MARKETABLE SECURITES (Details Narrative) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Aug. 01, 2012
Marketable Securities [Abstract]
Mediswipe, Inc.'s common stock	600,000	1,000,000
Shares sold			50,000
Amount gained	$ 7,054
Net carrying value	$ 263,400	$ 72,150

XML

Statements of Cash Flows (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:
Net loss	$ (22,445)	$ (138,727)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	99	99
Amortization of discount on convertible note		12,329
Change in fair market value of derivative liabilities		(11,180)
Stock based compensation		106,750
Gain on sales of marketable securities	(7,054)	1,900
Change in operating assets and liabilities:
Increase in accounts receivable	(1,447)	(3,126)
Increase in prepaid assets	(1,500)
Increase in security deposit	(700)
Increase in accounts payable and accrued expenses	7,826	4,558
Net cash used in operating activities	(25,221)	(27,397)
Cash flows from investing activities:
Proceeds from sales of marketable securities	16,554
Purchase of computer equipment		(1,929)
Net cash provided by (used in) investing activities	16,554	(1,929)
Cash flows from financing activities:
Increase in amount due shareholders	21,150	1,701
Repayments of convertible note	(700)
Net cash provided by financing activities	14,500	1,701
Net (decrease) increase in cash and cash equivalents	5,483	(29,625)
Cash and cash equivalents, beginning	3,912	40,618
Cash and cash equivalents, ending	9,395	12,993
Cash paid for interest
Cash paid for income taxes
Schedule of Non-Cash Investing and Financing Activities
Reclassification of derivative liability upon repayment of convertible debt	$ 6,373

XML

5 MARKETABLE SECURITES

3 Months Ended

Mar. 31, 2014

Marketable Securities [Abstract]

MARKETABLE SECURITES

Note 5 – Marketable Securities

The Company’s marketable securities consist solely of 600,000 and 1,000,000, as of March 31, 2014, and December 31, 2013, respectively, of shares of Mediswipe, Inc.’s (“Mediswipe”) common stock, issued to the Company in connection with the Company’s formation in 2010. The Company classifies its marketable securities as available-for-sale securities, which are carried at their fair value based on the quoted market prices of the securities with unrealized gains and losses, net of deferred income taxes, reported as accumulated other comprehensive income (loss), a separate component of stockholders’ equity. Realized gains and losses on available-for-sale securities are included in net earnings in the period earned or incurred. During the three months ended March 31, 2014, the Company sold 50,000 shares of stock and recognized a gain of $7,054. The fair value of the Company’s holdings in Mediswipe’s common stock totaled $263,400 and $72,150 as of March 31, 2014, and December 31, 2013, respectively.

The following summarizes the carrying value of marketable securities as of March 31, 2014 and December 31, 2013:

	2014		2013
Historical cost	$114,000		$123,500
Unrealized gain (loss) included in accumulated  other comprehensive gain (loss)		149,400		(51,350	)
Net carrying value	$	263,400	$	72,150

XML

6 RELATED PARTY TRANSACTIONS (Details Narrative) (USD $)	3 Months Ended	12 Months Ended						3 Months Ended			3 Months Ended
	Mar. 31, 2013	Dec. 31, 2013	Mar. 31, 2014	Sep. 03, 2013	Dec. 31, 2012	Aug. 01, 2012	May 09, 2012	Mar. 31, 2014 Michael Friedman President	Mar. 31, 2013 Michael Friedman President	Dec. 31, 2013 Michael Friedman President	Mar. 31, 2014 Barry Hollander CFO	Mar. 31, 2013 Barry Hollander CFO	Mar. 31, 2014 Mr Canton Chairman	Dec. 31, 2013 Mr Canton Chairman
Expense in Management fees paid								$ 13,500	$ 3,003		$ 9,000	$ 9,000
Non-qualified stock option to purchase common stock						800,000
Exercise price						$ 0.30
Stock compensation expense	63,000
Amount due to stockholders								44,997		32,847			66,667	66,667
Common stock owned by Mediswipe, Inc.					6,000,000
Approximately representation of Company's outstanding common stock					0.32
Common stock distributed to Company's shareholders				6,000,000
Amount owed to Mediswipe		74,895	83,895
Convertible promissory note							50,000
Convertible promissory note bears an interest of:							0.08
Percentage of the lowest closing bid price							0.065
Limitations on holder's right for conversion - percentage							4.9
Interest Rate							12.00%
Amount of the Note the Company repaid		43,000
Debt discount		50,000
Initial loss on valuation of derivative liabilities		1,282
Initial fair value of the derivative liability		51,282
Fair Value					$ 25,329

XML

2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Company's financial instruments measured at fair value (Details) (USD $)	3 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Accounting Policies [Abstract]
Cost of revenues, as reported	$ 82,003
Cost of revenues, adjustments	31,250
Cost of revenues, restated	113,253
Gross profit, as reported	11,809
Gross profit, adjustments	(31,250)
Gross profit, restated	(19,441)
Operating loss, as reported	(108,502)
Operating loss, adjustments	(31,250)
Operating loss, restated	(139,752)
Net loss, as reported	(107,477)
Net loss, adjustments	(31,250)
Net loss, restated	(138,727)
Comprehensive income, as reported	235,523
Comprehensive income, adjustments	(31,250)
Comprehensive income, restated	206,173
Net loss per share, as reported	$ 0.00
Net loss per share, adjustments	$ (0.01)
Net loss per share, restated	$ (0.01)
Level I, Derivative Liability
Level I, Marketable Securities	263,400	72,150
Level II, Derivative Liability
Level II, Marketable Securities
Level III, Derivative Liability		6,373
Level III, Marketable Securities
Total Level I	263,400	72,150
Total Level II
Total Level III		$ 6,373